Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocytes
B Miao, M Geng, J Li, F Li, H Chen, H Guan… - Biochemical …, 2004 - Elsevier
Sulfated polymannuroguluronate (SPMG), a marine sulfated polysaccharide, has entered
the Phase II clinical trial in China as the first anti-acquired immune deficiency syndrome …
the Phase II clinical trial in China as the first anti-acquired immune deficiency syndrome …
Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocytes
B Miao, M Geng, J Li, F Li, H Chen… - Biochemical …, 2004 - pubmed.ncbi.nlm.nih.gov
Sulfated polymannuroguluronate (SPMG), a marine sulfated polysaccharide, has entered
the Phase II clinical trial in China as the first anti-acquired immune deficiency syndrome …
the Phase II clinical trial in China as the first anti-acquired immune deficiency syndrome …
Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocytes.
B Miao, M Geng, J Li, F Li, H Chen… - Biochemical …, 2004 - europepmc.org
Sulfated polymannuroguluronate (SPMG), a marine sulfated polysaccharide, has entered
the Phase II clinical trial in China as the first anti-acquired immune deficiency syndrome …
the Phase II clinical trial in China as the first anti-acquired immune deficiency syndrome …
Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocytes
B Miao, M Geng, J Li, F Li, H Chen, H Guan… - Biochemical …, 2004 - infona.pl
Sulfated polymannuroguluronate (SPMG), a marine sulfated polysaccharide, has entered
the Phase II clinical trial in China as the first anti-acquired immune deficiency syndrome …
the Phase II clinical trial in China as the first anti-acquired immune deficiency syndrome …
[引用][C] Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocytes
B MIAO, M GENG, J LI, F LI, H CHEN… - Biochemical …, 2004 - pascal-francis.inist.fr
Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS)
drug candidate, targeting CD4 in lymphocytes CNRS Inist Pascal-Francis CNRS Pascal and …
drug candidate, targeting CD4 in lymphocytes CNRS Inist Pascal-Francis CNRS Pascal and …
Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocytes
B Miao, M Geng, J Li, F Li, H Chen, H Guan… - Biochemical …, 2004 - infona.pl
Sulfated polymannuroguluronate (SPMG), a marine sulfated polysaccharide, has entered
the Phase II clinical trial in China as the first anti-acquired immune deficiency syndrome …
the Phase II clinical trial in China as the first anti-acquired immune deficiency syndrome …